Scientific Reports,
Год журнала:
2024,
Номер
14(1)
Опубликована: Ноя. 7, 2024
KRAS
is
one
of
the
most
frequently
mutated
oncogenes
across
various
cancers.
Oncogenic
mutations
rewire
cellular
signaling,
leading
to
significant
alterations
in
gene
expression.
RNA-binding
proteins
(RBPs)
play
a
pivotal
role
expression
regulation
by
post-transcriptionally
controlling
aspects
RNA
metabolism.
It
has
become
clear
that
interactions
between
RBPs
and
are
dysregulated
numerous
However,
how
oncogenic
reshape
post-transcriptional
regulatory
network
mediated
remains
poorly
understood.
In
this
study,
we
systematically
dissected
KRAS-driven
RNA-RBP
networks.
We
identified
35
cancer-associated
with
either
increased
or
decreased
binding
upon
activation,
including
PDCD11,
which
essential
for
viability
mutant
cancers,
ELAVL2,
regulates
cell
migration
lung
Our
study
serves
as
crucial
resource
elucidating
RBP
networks
cancers
may
provide
new
avenues
therapeutic
strategies
targeting
malignancies.
Cell Death and Disease,
Год журнала:
2025,
Номер
16(1)
Опубликована: Фев. 8, 2025
RNA-based
therapeutics
highlighted
novel
approaches
to
target
either
coding
or
noncoding
molecules
for
multiple
diseases
treatment.
In
breast
cancer
(BC),
a
multitude
of
deregulated
long
RNAs
(lncRNAs)
have
been
identified
as
potential
therapeutic
targets
also
in
the
context
antiestrogen
resistance,
and
RNA
binding
activity
estrogen
receptor
α
(ERα)
points
additional
candidates
interfere
with
estrogenic
signaling.
A
set
lncRNAs
was
selected
among
ERα-associated
BC
cell
nuclei
due
their
roles
processes
such
transcriptional
regulation
epigenetic
chromatin
modifications.
Native
immunoprecipitation
nuclear
ERα-interacting
coupled
NGS
(RIP-Seq)
performed
MCF-7
cells,
leading
identification
essential
interacting
multi-molecular
regulatory
complexes.
Among
these,
PVT1,
FGD5-AS1
EPB41L4A-AS1
were
further
investigation.
Functional
assays
transcriptome
analysis
following
lncRNA
knock-down
indicated
PVT1
master
modulator
some
most
relevant
hallmarks,
proliferation,
apoptosis,
migration
response
hypoxia.
addition,
targeted
experiments
key
factor
composition
PRC2-ERα
network
involved
downregulation
tumor
suppressor
genes,
including
BTG2.
Abstract
Therapeutic
resistance
presents
a
significant
hurdle
in
combating
inflammatory
breast
cancer
(IBC),
adding
to
the
complexity
of
its
management.
To
investigate
these
mechanisms,
we
conducted
comprehensive
analysis
using
transcriptomic
and
proteomic
profiling
preclinical
model
alone
with
correlates
treatment
response
IBC
patients.
This
included
SUM149
cell
lines
derived
from
treatment-naïve
patients,
along
acquired
drug
(rSUM149)
others
state
reversal
(rrSUM149),
aiming
uncover
networks.
We
identified
specific
ribosomal
proteins
associated
acquiring
resistance.
These
correlated
elevated
levels
molecular
markers
such
as
pERK,
CDK1,
XIAP,
SOD2.
While
rrSUM149
cells
largely
normalized
expression
profile,
VIPER
revealed
persistent
alterations
process-related
(AGO2,
Exportin
1,
RPL5),
suggesting
their
continued
involvement
Moreover,
genes
linked
processes
were
significantly
enriched
(
P
<
0.001)
among
overexpressed
patients
n
=
87)
who
exhibited
pathological
complete
(pCR)
neoadjuvant
chemotherapy.
Given
common
hyperactivation
MAPK
tumors,
including
rSUM149,
evaluated
Merestinib,
multikinase
inhibitor
clinical
trials.
It
effectively
targeted
pERK
peIF4E
pathways,
suppressed
downstream
targets,
induced
death
drug-resistant
rSUM149
cells,
showed
synergistic
effects
another
tyrosine
kinase
(Lapatinib)
parental
cells.
underscores
impact
on
protein
synthesis
signaling,
crucial
for
translational
dependence
In
summary,
our
study
elucidates
adaptive
changes
therapy
pauses,
guiding
precision
medicine
approaches
this
challenging
type.
Frontiers in Pharmacology,
Год журнала:
2023,
Номер
14
Опубликована: Июнь 8, 2023
Chemotherapy
resistance
remains
a
major
challenge
in
the
treatment
of
gynecologic
malignancies.
Increasing
evidence
suggests
that
circular
RNAs
(circRNAs)
play
significant
role
conferring
chemoresistance
these
cancers.
In
this
review,
we
summarize
current
understanding
mechanisms
by
which
circRNAs
regulate
chemotherapy
sensitivity
and
We
also
discuss
potential
clinical
implications
findings
highlight
areas
for
future
research.
CircRNAs
are
novel
class
RNA
molecules
characterized
their
unique
structure,
confers
increased
stability
to
degradation
exonucleases.
Recent
studies
have
shown
can
act
as
miRNA
sponges,
sequestering
miRNAs
preventing
them
from
binding
target
mRNAs.
This
lead
upregulation
genes
involved
drug
pathways,
ultimately
resulting
decreased
chemotherapy.
several
specific
examples
been
implicated
cancers,
including
cervical
cancer,
ovarian
endometrial
cancer.
applications
circRNA-based
biomarkers
predicting
response
guiding
decisions.
Overall,
review
provides
comprehensive
overview
state
knowledge
regarding
By
elucidating
underlying
sensitivity,
work
has
important
improving
patient
outcomes
developing
more
effective
therapeutic
strategies
challenging
Critical Reviews in Oncology/Hematology,
Год журнала:
2024,
Номер
195, С. 104271 - 104271
Опубликована: Янв. 23, 2024
RNA-binding
proteins
(RBPs)
refer
to
a
class
of
that
participate
in
alternative
splicing,
RNA
stability,
polyadenylation,
localization
and
translation
RNAs,
thus
regulating
gene
expression
post-transcriptional
manner.
Dysregulation
RNA-RBP
interaction
contributes
various
diseases,
including
cancer.
In
breast
cancer,
disorders
RBP
function
influence
the
biological
characteristics
tumor
cells.
Targeting
RBPs
has
fostered
development
innovative
therapies
for
However,
RBP-related
mechanisms
cancer
are
not
completely
clear.
this
review,
we
summarize
regulatory
their
signaling
crosstalk
Specifically,
emphasize
potential
certain
as
prognostic
factors
due
effects
on
proliferation,
invasion,
apoptosis,
therapy
resistance
Most
importantly,
present
comprehensive
overview
latest
therapeutic
strategies
novel
targets
have
proven
be
useful
treatment
Non-coding RNA Research,
Год журнала:
2024,
Номер
9(4), С. 1280 - 1291
Опубликована: Май 20, 2024
Ovarian
cancer
(OC)
is
the
most
common
cause
of
death
in
female
cancers.
The
prognosis
OC
very
poor
due
to
delayed
diagnosis
and
identification
patients
advanced
stages,
metastasis,
recurrence,
resistance
chemotherapy.
As
chemotherapy
with
platinum-based
drugs
such
as
cisplatin
(DDP)
main
treatment
cases,
DDP
an
important
obstacle
achieving
satisfactory
therapeutic
efficacy.
Consequently,
knowing
different
molecular
mechanisms
involved
necessary
achieve
new
approaches.
According
numerous
recent
studies,
non-coding
RNAs
(ncRNAs)
could
regulate
proliferation,
differentiation,
apoptosis,
chemoresistance
many
cancers,
including
OC.
Most
these
ncRNAs
are
released
by
tumor
cells
into
human
fluid,
allowing
them
be
used
tools
for
diagnosis.
CircRNAs
ncRNA
family
members
that
have
a
role
initiation,
progression,
regulation
various
In
current
study,
we
investigated
roles
several
circRNAs
their
signaling
pathways
on
progression
also
during
Frontiers in Molecular Biosciences,
Год журнала:
2024,
Номер
11
Опубликована: Июнь 6, 2024
Primary
Sclerosing
Cholangitis
(PSC)
is
a
persistent
inflammatory
liver
condition
that
affects
the
bile
ducts
and
commonly
diagnosed
in
young
individuals.
Despite
efforts
to
incorporate
various
clinical,
biochemical
molecular
parameters
for
diagnosing
PSC,
it
remains
challenging,
no
biomarkers
characteristic
of
disease
have
been
identified
hitherto.
PSC
linked
with
an
uncertain
prognosis,
there
pressing
need
explore
multiomics
databases
establish
new
biomarker
panel
early
detection
PSC’s
gradual
progression
into
Cholangiocarcinoma
(CCA)
development
effective
therapeutic
interventions.
Apart
from
non-coding
RNAs,
other
components
Ribonucleoprotein
(RNP)
complex,
such
as
RNA-Binding
Proteins
(RBPs),
also
hold
great
promise
due
their
versatile
expression
pathological
conditions.
In
present
review,
update
on
RBP
transcripts
show
dysregulated
CCA
provided.
Moreover,
by
utilizing
bioinformatic
data
mining
approach,
we
give
insight
those
exhibit
differential
gall
bladder,
well
body
fluids,
are
promising
predicting
prognosis
PSC.
Expression
were
bioinformatically
extracted
public
repositories
usingTCGA
Bile
Duct
Cancer
dataset
specific
NCBI
GEO
datasets
both
CCA;
more
specifically,
RBPs
annotations
obtained
World
database.
Interestingly,
our
comprehensive
analysis
shows
elevated
non-canonical
RBPs,
FANCD2
,
microtubule
dynamics
regulator,
ASPM
fluids
patients
compared
respective
controls,
same
trend
being
observed
bladder
cancer
tissues.
Consequently,
manipulation
tissue
might
be
considered
strategy
mitigate
onset
patients,
warrants
further
experimental
investigation.
The
performed
herein
may
helpful
identification
non-invasive
its
CCA.
conclusion,
future
clinical
research
should
investigate
depth
full
potential
human
pathologies.
Frontiers in Molecular Biosciences,
Год журнала:
2023,
Номер
10
Опубликована: Ноя. 16, 2023
In
recent
years,
RNA
has
gained
traction
both
as
a
therapeutic
molecule
and
target
in
several
human
pathologies.
this
review,
we
consider
the
approach
of
targeting
using
small
molecules
for
research
purposes.
Given
primary
challenge
presented
by
low
structural
diversity
RNA,
discuss
potential
RNA:
protein
interactions
to
enhance
sequence
specificity
drug
candidates.
We
review
available
tools
inherent
challenges
approach,
ranging
from
adapted
bioinformatics
vitro
cellular
high-throughput
screening
functional
analysis.
further
two
critical
steps
RNA/protein
interactions:
first,
integration
silico
analyses
improve
efficacy
identifying
scaffolds
with
high
affinity,
second,
increasing
likelihood
on-target
compounds
cells
through
combination
approaches
assays.
anticipate
that
development
new
class
prevent
physio-pathological
mechanisms
could
significantly
expand
arsenal
effective
compounds.
Cell Death Discovery,
Год журнала:
2023,
Номер
9(1)
Опубликована: Дек. 19, 2023
Tumor
metastasis
severely
limits
the
prognosis
of
gastric
cancer
patients.
RNA-binding
proteins
(RBPs)
are
crucial
in
tumor
metastasis,
yet
there
is
limited
research
into
their
involvement
cancer.
Here,
we
found
that
ESRP1,
a
RBP
specific
epithelial
cells,
important
regulating
cells.
ESRP1
negatively
correlated
with
distant
and
lymph
node
And
demonstrated
inhibit
migration
invasion
vitro
vivo.
Mechanistically,
promotes
exon
11
alternative
splicing
CLSTN1
pre-mRNA.
The
post-splicing
short
stabilizes
Ecadherin/β-catenin
binding
structure,
β-catenin
protein
ubiquitination
degradation,
thereby
inhibiting
Our
study
highlights
role
extends
its
mechanism.
These
results
provide
possibility
for
to
become
therapeutic
targets
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(17), С. 13127 - 13127
Опубликована: Авг. 23, 2023
The
RNA-binding
protein
human
antigen
R
(HuR)
regulates
stability,
translation,
and
nucleus-to-cytoplasm
shuttling
of
its
target
mRNAs.
This
has
been
progressively
recognized
as
a
relevant
therapeutic
for
several
pathologies,
like
cancer,
neurodegeneration,
well
inflammation.
Inhibitors
mRNA
binding
to
HuR
might
thus
be
beneficial
against
variety
diseases.
Here,
we
present
the
rational
identification
structurally
novel
inhibitors.
In
particular,
by
combining
chemoinformatic
approaches,
high-throughput
virtual
screening,
RNA–protein
pulldown
assays,
demonstrate
that
4-(2-(2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)hydrazineyl)benzoate
ligand
exhibits
dose-dependent
inhibition
effect
in
experiments.
Importantly,
chemical
scaffold
is
new
with
respect
currently
known
inhibitors,
opening
up
avenue
design
pharmaceutical
agents
targeting
this
important
protein.